MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and ...
In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...
AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...
Novo Nordisk has stopped development of its next-generation oral GLP-1 analog OG2023SC. The Danish drugmaker took the action after making progress with an enhanced version of its existing oral ...
The oral solution is supplied in a 120mL bottle containing 25mg of sitagliptin per mL. Brynovin ™, an oral solution formulation of sitagliptin, is now available from Azurity Pharmaceuticals. Brynovin ...
The approval of Radicava ORS was based on a bioavailability study and a safety study. The Food and Drug Administration (FDA) has approved Radicava ORS ® (edaravone) oral suspension for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback